Skip to main content
Market intelligence
BDXHealthcare

Becton Dickinson & Co. insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 26, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 26, 2026Michael FeldEVP, Chief Revenue OfficerSale75$152.80$11,460
Jun 24, 2026Michael David GarrisonEVP & Pres Med.Essntl&BioPharmSale1,100$145.66$160,226
Jun 10, 2026Michael David GarrisonEVP & Pres Med.Essntl&BioPharmSale1,100$151.48$166,628